1-10 of 10
Moo-Rim Park, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

18 f-FDG PET/CT and the Revised International Staging System Are More Discriminating of Survival Outcomes in Newly Diagnosed Multiple Myeloma

Free
Sung-Hoon Jung, MD, Seong Young Kwon, Jung-Joon Min, Hee Seung Bom, Seo-Yeon Ahn, MD, Seung-Yeon Jung, Seung-Shin Lee, MD, Moo-Rim Park, MD, Deok-Hwan Yang, MD, Jae-Sook Ahn, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4483.
https://doi.org/10.1182/blood-2018-99-112354
Published: 2018
Journal Articles

Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)

Free
Kyoung Ha Kim, Lee Jae Hoon, Mark Lee, Kim Hoon-Gu, Young Rok Do, Yong Park, MD PhD, Sung Yong Oh, MD, Ho-Jin Shin, MD PhD, Won Seog Kim, Sung-Kyu Park, MD, Jong-Ho Won, Jee Hyun Kong, Moo-Rim Park, MD, Je-Jung Lee, Jae-Yong Kwak, Hye Jin Kang, MD PhD, Yeung-Chul Mun
Journal: Blood
Blood (2016) 128 (22): 3466.
https://doi.org/10.1182/blood.V128.22.3466.3466
Published: 2016
Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.

Free
Jae Hoon Lee, Junshik Hong, MD, Jin Seok Kim, June-Won Cheong, MD, Cheolwon Suh, MD, Kihyun Kim, MD, Yang Soo Kim, MD, Se-Ryeon Lee, MD, Sung Hwa Bae, Young-Don Joo, MD, PhD, Sang Min Lee, MD, Hyeon Seok Eom, MD, Eunkyung Park, MD, Sung-Soo Yoon, MD, PhD, Inho Kim, MD, PhD, Jae-Yong Kwak, MD, Chang-Ki Min, Jeong-A Kim, MD.PhD., Moo-Rim Park, MD, Sung Hyun Kim, MD, Hye Jin Kang, MD, Min Kyoung Kim, MD, Hawk Kim, MD, Yeung-Chul Mun, Hoon-Gu KIM, MD, Moon Hee Lee, MD
Journal: Blood
Blood (2012) 120 (21): 3106.
https://doi.org/10.1182/blood.V120.21.3106.3106
Published: 2012
Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Induction Chemotherapy Followed by High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma; Open-Labelled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis

Free
Jin Seok Kim, Cheolwon Suh, MD, June-Won Cheong, MD, PhD, Kihyun Kim, MD, Yang Soo Kim, Se-Ryeon Lee, MD, PhD, Sung Hwa Bae, Young-Don Joo, Sang Min Lee, MD, Hyeon Seok Eom, Eunkyung Park, MD, PhD, Sung-Soo Yoon, MD, PhD, Inho Kim, Jae-Yong Kwak, MD, PhD, Chang-Ki Min, Jeong-A Kim, Moo-Rim Park, MD, Sung Hyun Kim, Hye Jin Kang, Min Kyoung Kim, Hawk Kim, Yeung-Chul Mun, Hoon-GU KIM, Moon Hee Lee, Jae Hoon Lee, MD
Journal: Blood
Blood (2011) 118 (21): 2044.
https://doi.org/10.1182/blood.V118.21.2044.2044
Published: 2011
Journal Articles

Hematopoietic Stem Cell Repopulation Modulated by ROS-Detoxifying Enzymes,

Free
Richard XuFeng, MD, Moo-Rim Park, MD, Weimin Miao, M.D., Ph.D., Hui Yu, MD, PhD, Michael W. Epperly, Ph.D., Joel S. Greenberger, MD, Tao Cheng, MD
Journal: Blood
Blood (2011) 118 (21): 4172.
https://doi.org/10.1182/blood.V118.21.4172.4172
Published: 2011
Journal Articles

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Free
Byung Woog Kang, M.D., Shi Nae Kim, M.D., Joon Ho Moon, M.D., Joo-Seop Jung, Goon-Jae Cho, Deog Yeon Jo, Yeo-Kyeoung Kim, Hyeoung Joon Kim, MD, Hun-Mo Ryoo, Hyeon Seok Eom, MD, PhD, Sang Min Lee, Young-Don Joo, Jong Ho Won, Moo-Rim Park, MD, Min Kyoung Kim, Myung Soo Hyun, MD, PhD, Sang Kyun Sohn, M.D.
Journal: Blood
Blood (2009) 114 (22): 3381.
https://doi.org/10.1182/blood.V114.22.3381.3381
Published: 2009
Journal Articles

Polymorphisms in Myeloid Cell Leukemia-1 and the Risk for Acute Myeloid Leukemia

Free
Hee Nam Kim, PhD, Li Yu, Nan young Kim, Il-Kwon Lee, Yeo-Kyeoung Kim, Deok-Hwan Yang, Je-Jung Lee, MD, PhD, Hee-je Kim, Woo-Sung Min, Moo-Rim Park, MD, Deog-Yeon Jo, Jong-Ho Won, Jae-Yong Kwak, Hyeoung- Joon Kim
Journal: Blood
Blood (2008) 112 (11): 3977.
https://doi.org/10.1182/blood.V112.11.3977.3977
Published: 2008
Journal Articles

GST T1 and GST M1 Polymorphisms Are Associated with the Risk of Acute Myeloid Leukemia

Free
Hee Nam Kim, PhD, Li Yu, Nan Young Kim, Il-Kwon Lee, Yeo-Kyeoung Kim, Deok-Hwan Yang, Je-Jung Lee, MD, PhD, Hee-Je Kim, Woo- Sung Min, Moo-Rim Park, MD, Deog-Yeon Jo, MD, PhD, Jong-Ho Won, Jae-Yong Kwak, Hyeoung Joon Kim, MD
Journal: Blood
Blood (2008) 112 (11): 3978.
https://doi.org/10.1182/blood.V112.11.3978.3978
Published: 2008
Journal Articles

Durable Remission of Acute Panmyelosis with Myelofibrosis Following Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation.

Free
Moo-Rim Park, MD, Hyeok Shim, MD, Young-Jin Lee, MD
Journal: Blood
Blood (2005) 106 (11): 5305.
https://doi.org/10.1182/blood.V106.11.5305.5305
Published: 2005
Journal Articles

Two Single Nucleotide Polymorphisms of the ETS2 Transcriptional Factor Gene Predispose Individuals to High-Risk Acute Myelogenous Leukemia (AML).

Free
Il-Kwon Lee, PhD, Jeong-Hwa Choi, MSc, Yeo-Kyeoung Kim, MD, PhD, Hee Nam Kim, MSc, Kyeong-Soo Park, MD, PhD, Je-Jung Lee, MD, PhD, Myung Geun Shin, MD, PhD, Chan Choi, MD, PhD, Hoon Kook, MD, PhD, Tae Ju Hwang, MD, PhD, Moo Rim Park, MD, PhD, Deog Yeon Jo, MD, PhD, Jong Ho Won, MD, PhD, Hyeoung-Joon Kim, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2729.
https://doi.org/10.1182/blood.V106.11.2729.2729
Published: 2005